Quander

40:05

New Guidance for Investigation of Vitamin B12 Deficiency: Considerations for Transitioning to...

more_vert

Labroots check_circle

62 views 2 months ago

45:37

Advanced solutions for the development of Gene Therapies

more_vert

Labroots check_circle

65 views 3 months ago

31:00

Retaining Cell Viability and Morphology in IPSCs: Vital Tools for Research

more_vert

Labroots check_circle

32 views 3 months ago

00:47:05

Next-Gen Lab Informatics Part 3: Procedure Execution

more_vert

Labroots check_circle

29 views 3 months ago

36:08

Point of Care Testing for Microbial Infectious Diseases The Urgent Need for New Novel Tests

more_vert

Labroots check_circle

109 views 5 months ago

39:36

Applications of Cellular Assays for Understanding Drug Disposition of Protein Therapeutics

more_vert

Labroots check_circle

220 views 5 months ago

52:27

Exploring the Development & Optimization of mRNA Delivery Systems to Advance mRNA-based medicines

more_vert

Labroots check_circle

220 views 5 months ago

45:59

Exploring the Possibilities of Loop mediated Isothermal Amplification

more_vert

Labroots check_circle

183 views 8 months ago

30:59

Overcome a "Big" Challenge: Progress on Mass Spectrometric Analysis of Large Molecules

more_vert

Labroots check_circle

84 views 8 months ago

29:02

Panel Presentation: Curating the Genome to Drive Precision Diagnosis in Clinical Care

more_vert

Labroots check_circle

22 views 8 months ago

33:16

xMAP® Technology: The Year in Review

more_vert

Labroots check_circle

71 views 1 year ago

5:34

New Innovations in Cell Therapy

more_vert

Labroots check_circle

52 views 1 year ago

29:23

Armoring T Cells with Engineered Fusion Proteins Enhances Therapeutic Efficacy Against Hematologi...

more_vert

Labroots check_circle

258 views 2 years ago

1:04:09

WEBINAR - Real-time Whole Genome Sequencing Surveillance for Healthcare Outbreak Detection and...

more_vert

Labroots check_circle

434 views 2 years ago

0:59

George Church, Ph.D. Talks About His Experience with LabRoots!

more_vert

Labroots check_circle

406 views 5 years ago

2:19

LabRoots Microbiology & Immunology Welcome Greeting

more_vert

Labroots check_circle

95 views 5 years ago

00:55:48

Cannabis as Immunonotherapy for 21st Century Acquired Immune Deficiencies

more_vert

Labroots check_circle

40K views 6 years ago

,Presented At: Cannabis Sciences Virtual Event 2018 Presented By: Judy Mikovits, PhD - Founder/Consultant at M.A.R.C. INC and Director of Cancer Biology at EpiGenX Pharmaceuticals Speaker Bio: Dr. Judy A. Mikovits earned a BA in Chemistry with a specialization in biology from the University of Virginia in 1980 and a PhD in biochemistry and molecular biology from George Washington University in 1992. Upon graduation from UVA, she went directly to the National Cancer Institute in Frederick Maryland where she developed purification methods for Interferon alpha. It was this Interferon which was used in the first immune therapy treatment for hairy cell leukemia in 1986. In 1986-7, prior to enrolling in graduate school. she went to Upjohn Pharmaceuticals in Kalamazoo Michigan to develop production methods to insure biological materials manufactured using human blood products were free of contamination from HIV-1. Her PhD thesis defense entitled "Negative Regulation of HIV Expression in Monocytes" changed the paradigm for therapeutic treatment of HIV. For this work, she was awarded the graduate student of the year in 1991. In her thirty-five-year quest to understand and develop therapies for chronic diseases, she has co-authored seminal papers culminating at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and HIV/AIDs drug development. In 2006, Dr. Mikovits became attracted to the plight of families with neuroimmune diseases including ME/CFS and Autism and was primarily responsible for demonstrating the relationship between environmentally acquired immune dysfunction, chronic inflammation and these diseases. Her pioneering work during a twenty year career at the National Cancer Institute includes the discovery of the modulation of DNA Methylation machinery by human retro viral infection and the development of the concept of inflammatory cytokines and chemokine signatures of infection and disease, which was first published in 1999, when Dr. Mikovits directed the Laboratory of Antiviral Drug Mechanisms in developing therapeutics and diagnostics for HIV/AIDS and AIDS associated malignancies. Webinar: Cannabis as Immunonotherapy for 21st Century Acquired Immune Deficiencies Webinar Abstract: It has only been in the last 20 years that we, the scientific/medical community, have appreciated the role of the endogenous Cannabinoid system (ECS) in maintaining a healthy immune system and brain. More recently, we recognized that the ECS is critical for stem cell development and homeostasis. The phytocannabinoid, THC is a modulator of Hematopoietic Stem Cells (HSC). It acts in part via stimulation of TGF beta production. The modulation of TGF beta, HSC and the NFkB by other natural product immunotherapy via some of the same pathways as THC suggest opportunities for synergy and decreasing psychoactive effects. Combinations of phytocannabinoiss can be used as stem cell and immune therapy in combination with other natural products and chemotherapy as curative treatment strategies for cancer, AIDS, Autoimmune disease and chronic inflammatory diseases. Moreover, Evidence is accumulating that THC is actually reduces opioid addiction by modulating endogenous opioids. Endogenous opioids are peptides derived from food which can also modulate immune cells including hematopoietc stem cells and be valuable therapeutics against HIV/AIDS and Cancer as our collaborator, Candace Pert demonstrated in the 1980s when she/we developed peptide T as an AIDS and cancer therapeutic (book Molecules of Emotion). Endocannabinoids, phyto-cannabinoids, and opioids modulate the immune system, hematopoietic and mesenchymal stem cells, it may also modulate the opioid pathways to reduce addiction. Earn PACE/CME Credits: 1. Make sure you’re a registered member of LabRoots (https://www.labroots.com/virtual-event/cannabis-sciences-2018) 2. Watch the webinar on YouTube above or on the LabRoots Website (https://www.labroots.com/virtual-event/cannabis-sciences-2018) 3. Click Here to get your PACE (Expiration date – March 29, 2020 12:00 PM)– http://www.labroots.com/credit/pace-credits/2816/third-party LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc

46:10

Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates

more_vert

Labroots check_circle

6.8K views 6 years ago

47:55

Josip Blonder - Mass spectrometry based clinical proteomics in biomarker research

more_vert

Labroots check_circle

2.6K views 11 years ago

2:58

LabRoots Video circa 2008 - the very beginning

more_vert

Labroots check_circle

40 views 11 years ago